Study evaluates efficacy of one and two doses of recombinant zoster vaccine overall, by time since vaccination, age and immunocompromise status, and with a late second dose.
Either amoxicillin or amoxicillin-clavulanate will clear infection, but the former is less likely to result in side-effects or antimicrobial resistance.